Suppr超能文献

白细胞介素-6 与缺血性脑卒中复发。

IL-6 and stroke recurrence in ischemic stroke.

机构信息

Spine Center, Sanbo Brain Hospital, Capital Medical University, Beijing, China.

出版信息

Biomark Med. 2024;18(17-18):739-747. doi: 10.1080/17520363.2024.2389038. Epub 2024 Sep 4.

Abstract

This study aimed to evaluate the predictive value of IL-6 for stroke recurrence in acute ischemic stroke. Patients who were admitted within 48 h of onset were included. At 3-month, stroke recurrence was assessed. IL-6 levels were measured in serum samples taken upon admission. Out of the 305 patients, 47 (15.4%) experienced a stroke recurrence. The risk of stroke recurrence increased by 8% (OR: 1.08; 95% CI: 1.04-1.11;  < 0.001) for every 1 pg/ml increase in IL-6 serum level, both in unadjusted and adjusted analyses (6%; OR: 1.06; 95% CI: 1.02-1.10;  = 0.001). The study supports the usefulness of IL-6 as a predictive biomarker for stroke recurrence after acute ischemic stroke.

摘要

这项研究旨在评估 IL-6 对急性缺血性脑卒中患者卒中复发的预测价值。纳入发病后 48 小时内入院的患者。在 3 个月时评估卒中复发情况。在入院时采集的血清样本中测量 IL-6 水平。在 305 名患者中,47 名(15.4%)发生卒中复发。在未调整和调整分析中,IL-6 血清水平每增加 1pg/ml,卒中复发的风险增加 8%(OR:1.08;95%CI:1.04-1.11;<0.001)(6%;OR:1.06;95%CI:1.02-1.10;=0.001)。该研究支持 IL-6 作为急性缺血性脑卒中后卒中复发的预测生物标志物的有用性。

相似文献

1
IL-6 and stroke recurrence in ischemic stroke.白细胞介素-6 与缺血性脑卒中复发。
Biomark Med. 2024;18(17-18):739-747. doi: 10.1080/17520363.2024.2389038. Epub 2024 Sep 4.

本文引用的文献

2
Targeting inflammation to reduce recurrent stroke.针对炎症以减少复发性中风。
Int J Stroke. 2024 Apr;19(4):379-387. doi: 10.1177/17474930231207777. Epub 2023 Oct 19.
4
Estimated Burden of Stroke in China in 2020.2020 年中国脑卒中发病与死亡负担估计。
JAMA Netw Open. 2023 Mar 1;6(3):e231455. doi: 10.1001/jamanetworkopen.2023.1455.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验